XOMA Royalty (XOMA) Cash from Operations Growth (5y) (2015 - 2026)
XOMA Royalty (XOMA) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.13% |
| Dec 31, 2025 | -18.24% |
| Jun 30, 2025 | 33.59% |
| Mar 31, 2025 | 24.27% |
| Dec 31, 2024 | 6.89% |
| Sep 30, 2024 | -33.69% |
| Jun 30, 2024 | 23.57% |
| Mar 31, 2024 | -28.96% |
| Dec 31, 2023 | -7.68% |
| Sep 30, 2023 | 5.22% |
| Jun 30, 2023 | -16.57% |
| Mar 31, 2023 | -5.10% |
| Dec 31, 2022 | 5.73% |
| Sep 30, 2022 | -16.21% |
| Jun 30, 2022 | 12.48% |
| Mar 31, 2022 | 41.19% |
| Dec 31, 2021 | 34.36% |
| Sep 30, 2021 | 23.90% |
| Jun 30, 2021 | 20.29% |
| Mar 31, 2021 | 43.79% |